Skip to Content
Søg Menu

EHA 2024 I The European Hematology Association

EHA 2024

Anne Stidsholt Roug

Opdateringer fra EHA: Nye behandlingsmuligheder for AML og APL

/ Anne Stidsholt Roug
EHA24 Play the Video

Tarec Christoffer El-galaly

Opsigtvækkende fremskridt på EHA for behandling af lymfom

/ Tarec Christoffer El-Galaly
EHA24Lymfom Play the Video
Maria Eugenia Chollet

Promising Avenues for the Development of Personalized Treatment for FVII Deficiency

/ Maria Eugenia Chollet
EHA24 Play the Video
Hanne Norseth

Vaccinating Against Mutated RAS in Multiple Myeloma

/ Hanne Norseth
EHA24Myelomatose Play the Video
Sergio Martinez Høyer

An Excellent Target with a Wide Therapeutic Window in del(5q) Myeloid Malignancies

/ Sergio Martinez Høyer
EHA24 Play the Video
Frida Bugge Askeland

Treating MRD Relapse After First-Line Treatment May Prolong PFS and OS in Myeloma Patients

/ Frida Bugge Askeland
EHA24Myelomatose Play the Video
Sigrid S. Skånland

From Genomic Precision Medicine to Functional Precision Medicine in Hematology

/ Sigrid S. Skånland
EHA24 Play the Video
Hent flere

Mest sete

MEDtalks

Management of ALL in Adults: 2024 ELN Recommendations

/ Hæmatologi / Henrik Hjorth-Hansen

Development of Prediction Models for Survival among Hodgkin Lymphoma Patients

/ Hæmatologi / Rasmus Rask Kragh Jørgensen

Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes

/ Hæmatologi / Ângela Sofia Gerós Mesquita

Artikler

EHA24: LBA – Potential Frontline Treatment for Elderly Patients with Untreated Mantle Cell Lymphoma

/ Hæmatologi / Isabella Rosa Staffe

EHA24: New Treatment Regimen Marks a Breakthrough for Patients with Multiple Myeloma

/ Hæmatologi / Isabella Rosa Staffe

EHA24: Professor John Gribben Awarded Prestigious EHA José Carreras Award 

/ Hæmatologi / Isabella Rosa Staffe
Jelena Jelicic

More Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Can Participate in Clinical Studies

/ Jelena Jelicic
EHA24Lymfom Play the Video
Elin Forsgren

Ibrutinib, Lenalidomide, and Rituximab in Relapsed Mantle Cell Lymphoma

/ Elin Forsgren
EHA24Myelomatose Play the Video
Ari Melnick

Presidential Symposium: Unmet Needs in the Lymphoma Field

/ Ari M. Melnick
EHA24Lymfom Play the Video
Bruno Paiva

Presidential Symposium: Innovative Tools for Disease Monitoring in Multiple Myeloma

/ Bruno Paiva
EHA24Myelomatose Play the Video
Sigrun Thorsteinsdottir

The Missing Link of Light Chain Smoldering Multiple Myeloma

/ Sigrun Thorsteinsdottir
EHA24Myelomatose Play the Video
Agoston Gyula Szabo

Dansk, investigator-initieret studie af lavdosis VEN-DEX hos patienter med RRMM og t(11;14) opnår en ORR på 50%

/ Agoston Gyula Szabo
EHA24Myelomatose Play the Video
Paolo Ghia

Promising Efficacy of Zanubrutinib + Venetoclax Treatment in Patients with High-Risk Treatment-Naïve CLL/SLL with Del 17p and/or TP53 Mutation

/ Paolo Ghia
EHA24CLL Play the Video
Alessandra Tedeschi

Impact of First-Year Dose Modifications of Acalabrutinib in Patients with CLL

/ Alessandra Tedeschi
EHA24CLL Play the Video
Nikolaj Nitschke

Functional Characterization for Germline Variants in Patients with MDS and AML

/ Nikolaj Juul Nitschke
EHA24AML Play the Video
Stine Ulrik Mikkelsen

LBA: Oral Vitamin C Supplementation for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions Might Improve OS

/ Stine Ulrik Mikkelsen
EHA24 Play the Video
Ingrid Glimelius

Elderly Patients with Mantle Cell Lymphoma Need to be More Intensively Treated

/ Ingrid Glimelius
EHA24Lymfom Play the Video
Sigrun Thorsteinsdottir

New Insights into MM Heterogeneity Among Different Age Groups

/ Sigrun Thorsteinsdottir
EHA24Myelomatose Play the Video
Hent flere

EHA 2023

Carsten Niemann

Overlevelsesgevinst for skrøbelige CLL-patienter i behandling med Imbruvica og Venclyxto

/ Carsten Utoft Niemann
EHA23CLL Play the Video

Ibrutinib keeps on delivering now as first-line treatment for older patients with mantle cell lymphoma

/ BestPractice Nordic
EHA22Lymfom

Superior safety profile for decitabine vs chemotherapy for older patient with AML

/ BestPractice Nordic
EHA22AML
Anna Sureda Balari

Epcoritamab with Rituximab and Lenalidomide (R2) for Patients with High-Risk Follicular Lymphoma

/ Anna Sureda Balari
EHA23Lymfom Play the Video
Mark Levis

Gilteritinib for Patients with Newly Diagnosed AML

/ Mark Levis
EHA23Ernæring Play the Video
Arnon Kater

MURANO Study Supports the Use of Fixed-Duration VenR in R/R CLL

/ Arnon Kater
EHA23CLL Play the Video
Evangelos Terpos

Daratumumab Combination Shows Positive Responses in Pretreated R/R Multiple Myeloma

/ Evangelos Terpos
EHA23Myelomatose Play the Video
Ryan Jacobs

News from EHA23 – A Promising Treatment Option for Follicular Lymphoma

/ Ryan Jacobs
EHA23Lymfom Play the Video
Barbara Eichhorst

What is New from EHA23 Regarding Treatment Strategies in First-Line CLL?

/ Barbara Eichhorst
EHA23CLL Play the Video
Eva Futtrup Maksten

Risk of Dementia in Older Patients Treated with Chemotherapy for Lymphoma

/ Eva Futtrup Maksten
EHA23LymfomDemens Play the Video

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

/ Evangelos Terpos / Jan Andreasen
EHA23Myelomatose
Alan Z. Skarbnik

New Research from EHA23 Points to Similar Effectiveness of Acalabrutinib and Zanubrutinib in R/R CLL Treatment

/ Alan Z. Skarbnik
EHA23CLL Play the Video
Hent flere

Højdepunkter fra EHA webinar 2022

Martin Hutchings

Hidtil højeste overall survival udfordrer 1.-linjebehandling ved Hodgkin lymfom

/ Martin Hutchings
Lymfom Play the Video
Martin Hutchings

To bispecifikke antistoffer er på vej mod godkendelse mod diffust storcellet B-celle lymfom

/ Martin Hutchings
B-celle lymfomLymfom Play the Video
Carsten Utoft Niemann

Tidsbegrænset venetoclax-baseret kombinationsbehandling opnår bedre PFS og MRD-negativitet ved behandling af CLL

/ Carsten Utoft Niemann
CLL Play the Video
Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video

MEDtalks fra EHA 2022

AML

MRD Status in NPM1 Mutated AML Should Be a Part of the Selection of Patients for Transplant in First Remission

/ Hæmatologi / Jad Othman

In the Era of Personalized Treatment and Targeted Therapies

/ Hæmatologi / Sergio Giralt

FLT3 Inhibitor Gilteritinib Shows Potential in Post-Transplant Maintenance for AML

/ Hæmatologi / Mark Levis

Treatment Options for FLT3 mutant acute myeloid leukemia

/ Hæmatologi / Eunice Wang

UK NCRI AML19 Trial – Liposomal daunorubicin and cytarabine had a significant survival benefit

/ Hæmatologi / Jad Othman
Se oversigt

CLL

No Increased Risk of Ventricular Arrhythmias and Sudden Death with Acalabrutinib

/ Hæmatologi / Jeff P. Sharman

Acalabrutinib in Frontline CLL Treatment: Six-Year Results from the Elevate-TN Study

/ Hæmatologi / Jeff P. Sharman

New Standard of Care for Previously Untreated CLL

/ Hæmatologi / Peter Hillmen

CAPTIVATE Study: CLL Combination Therapy of Ibrutinib and Venetoclax

/ Hæmatologi / Paolo Ghia

The Latest Advancements in the Treatment of CLL

/ Hæmatologi / John Gribben
Se oversigt

Lymfom

LBA: Acalabrutinib plus Bendamustine and Rituximab Show Significant Improvement in PFS for Elderly Patients with Mantle Cell Lymphoma

/ Hæmatologi / Michael Wang

The Blood Proteome Predicts High Risk of Relapse in Mantle Cell Lymphoma Patients

/ Hæmatologi / Patrick Nylund

EHA24: Updated Results on the AZD-0486 Trial for Treating Relapsed Refractory Follicular Lymphoma

/ Hæmatologi / Ryan Jacobs

Paradigm Changes in Hodgkin’s Lymphoma Treatments

/ Hæmatologi / Cathy Burton

Potential for Targeted and Immune-Facing Therapies for Patients with CNS Lymphoma

/ Hæmatologi / Jason Westin
Se oversigt

Myelomatose

Multiple Myeloma: Belantamab Mafodotin plus Pomalidomide and Dexamethasone Show Significant Higher PFS, Deep Response and OS vs Those of Standard of Care

/ Hæmatologi / Meletios A. Dimopoulos

Mechanisms of Sensitivity and Resistance of Multiple Myeloma to NK Cells Can Potentially Lead to New Treatments

/ Hæmatologi / Sara Gandolfi

EHA24: How I Treat Relapsed/Refractory Multiple Myeloma in Early Lines

/ Hæmatologi / Fredrik Schjesvold

Melflufen is Safe and Effective in Patients with Alkylator-Refractory Disease

/ Hæmatologi / Fredrik Schjesvold

A Potential New Standard of Care for Transplant-Eligible Patients with Multiple Myeloma

/ Hæmatologi / Pieter Sonneveld
Se oversigt

Abstracts fra EHA 2022

A novel CAR-T cell therapy thas proven highly effective for patients with RRMM

/ Hæmatologi / BestPractice Nordic

A new phase 3 trial shows significantly prolonged overall survival for patients with AML

/ Hæmatologi / BestPractice Nordic

Improved PFS is achievable using targeted therapy combinations with venetoclax in fit patients with treatment naïve CLL 

/ Hæmatologi / BestPractice Nordic

Treatment of Burkitt lymphoma with DA-EPOCH-R is associated with significant less infectious complications, transfusions, and hospitalization days 

/ Hæmatologi / BestPractice Nordic

Phase 2 study update: Epcoritamab demonstrates clinically meaningful and compelling efficacy in the treatment of R/R large B-cell lymphoma 

/ Hæmatologi / BestPractice Nordic

Phase 2 study update: Epcoritamab demonstrates clinically meaningful and compelling efficacy in the treatment of R/R large B-cell lymphoma 

  • / BestPractice Nordic

Se highlights EHA webinar 2022

Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video
Martin Hutchings

To bispecifikke antistoffer er på vej mod godkendelse mod diffust storcellet B-celle lymfom

/ Martin Hutchings
B-celle lymfomLymfom Play the Video
Carsten Utoft Niemann

Tidsbegrænset venetoclax-baseret kombinationsbehandling opnår bedre PFS og MRD-negativitet ved behandling af CLL

/ Carsten Utoft Niemann
CLL Play the Video
Martin Hutchings

Hidtil højeste overall survival udfordrer 1.-linjebehandling ved Hodgkin lymfom

/ Martin Hutchings
Lymfom Play the Video

Gå ikke glip af det nyeste fra Hæmatologi

Skriv dig på og få nye artikler, MEDtalks og magasiner i din indbakke

Send mig seneste nyt fra hæmatologi

Mere fra EHA 2022

Daniel Kristensen

Tillæg af andengenerations-FLT3-inhibitor til intensiv kemoterapi og konsolidering hos voksne med AML

/ Daniel Kristensen
EHA22AML Play the Video
Agoston Gyula Szabo

Værdien af højdosisbehandling som tillæg til Rvd induktion og konsolidering ved myelomatose

/ Agoston Gyula Szabo
EHA22Myelomatose Play the Video
Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video

Mere fra EHA 2021

Paolo Strati

Phase 1 Results in SIRPα Antibody CC-95251 in Combination with Rituximab in Patients with R/R NHL

/ Paolo Strati
EHA22Lymfom Play the Video
Kirsten Grønbæk

Hvad har GDPR betydet for den nordiske forskningsscene? Vigtigste take-aways fra EHA med Kirsten Grønbæk

/ clara
EHA22 Play the Video
Othman Al-sawaf

CLL14 study five-year results: Significantly superior efficacy for Ven-Obi

/ Othman Al-Sawaf
EHA22CLL Play the Video
Daniel Kristensen

Nyt landsdækkende studie stiller spørgsmålstegn ved betydningen af dosisreduktion hos overvægtige AML-patienter

/ Daniel Kristensen
EHA22AML Play the Video
Jean-Marie Michot

Novel oral agent with promising result as second-line treatment option for patients with T-Cell Lymphoma

/ Jean-Marie Michot
EHA22Lymfom Play the Video
Paul Richardson

A new randomized study suggests an improved depth of response and PFS for patients relapsing on Lenalidomide

/ Paul G. Richardson
EHA22Myelomatose Play the Video
Læs mere
Arnon Kater

The main clinical message from the Five-Year Analysis of Murano Study

/ Arnon P. Kater
EHA22CLL Play the Video
Paul Richardson

Longer PFS and higher ORR for frailty patients with R/R Multiple Myeloma treated with PVd than Vd

/ Paul G. Richardson
EHA22Myelomatose Play the Video
Jakob Nordberg Nørgaard

A new study shows that PTCD and MRD are complementary and necessary for doing a whole assessment on patient-response for myeloma patients

/ Jakob Nordberg Nørgaard
EHA22Myelomatose Play the Video
Back to top